v3.26.1
Commitments and Contingencies - Securities Purchase and Licensing Agreement and April 2024 Agreement for Gelclair (Details)
3 Months Ended
Apr. 12, 2024
Mar. 18, 2024
USD ($)
$ / shares
shares
Mar. 31, 2026
USD ($)
Mar. 31, 2026
EUR (€)
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Long-term Purchase Commitment            
Initial term of contract     5 years 5 years    
Non-refundable license fee     $ 215,040 € 200,000    
Deferred revenue     510,000     $ 552,000
Royalty expense     142,000   $ 39,000  
Amortization expense     467,000   467,000  
Insurance retention amount     100,000      
April 2024 Agreement for Gelclair            
Long-term Purchase Commitment            
Initial term of contract 5 years          
Royalty expense     142,000      
Amortization expense     34,000      
Carrying amount of license     183,000      
Gen            
Long-term Purchase Commitment            
Issuance of common stock (in shares) | shares   13        
Purchase price of common stock (per shares) | $ / shares   $ 157,500        
Gross proceeds from the issuance of common stock   $ 2,000,000        
Deferred revenue recognized as revenue   $ 850,000        
Initial term of contract   5 years        
License granted     43,000   $ 43,000  
Deferred revenue     510,000      
Deferred revenue, current     170,000      
Deferred revenue, noncurrent     $ 340,000